Dendritic cell-based immunotherapy in multiple myeloma (Q35665926)

9 August 2017

1 reference

title

Dendritic cell-based immunotherapy in multiple myeloma (English)

1 reference

9 August 2017

1 reference

1 reference

Qing Yi

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

44

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

2031-2038

1 reference

Myeloma proteins as tumor-specific transplantation antigens

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

ATM mutations are rare in familial chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Dendritic cells hold promise for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Proliferating dendritic cell progenitors in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Induction of interleukin 10-producing, nonproliferating CD4( ) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Graft-versus-myeloma effect in two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Idiotype-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Immunogenicity and cross‐reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Idiotype-specific T lymphocytes in monoclonal gammopathies: evidence for the presence of CD4 and CD8 subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Elevation of CD8 CD11b Leu-8− T cells is associated with the humoral immunodeficiency in myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Deregulated cytokine network and defective Th1 immune response in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Anti‐idiotypic T‐cell activation in multiple myeloma induced by M‐component fragments presented by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Dendritic cells injected via different routes induce immunity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Optimizing dendritic cell-based immunotherapy in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000116599

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1038/73193

Identifiers

DOI

10.1080/1042819031000116599

1 reference

9 August 2017

1 reference